Yong Li Yihong Liu Yanchun Qu Xian Chen Xin Qu Yongsong Ye Xiaohua Du Ying Cheng Mian Xu Haibo Zhang
10.3389/fimmu.2022.832593
Front Immunol
2022 May 6;13:832593.
anlotinib immune checkpoint inhibitors soft-tissue sarcomas toripalimab tumor mutational burden (tmb)
CC BY
https://pubmed.ncbi.nlm.nih.gov/35603147/
B7-H1 Antigen / genetics Sarcoma / diagnosis Sarcoma / drug therapy Sarcoma / genetics
B7-H1 Antigen / genetics Sarcoma / diagnosis Sarcoma / drug therapy Sarcoma / genetics Case Reports Adult Antibodies, Monoclonal, Humanized Biomarkers, Tumor / genetics Child, Preschool Female Humans Indoles Male Quinolines Antibodies, Monoclonal, Humanized B7-H1 Antigen Biomarkers, Tumor Indoles Quinolines anlotinib toripalimab
PMC9120574
35603147
Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy
2022